The
National Agency for Food and Drug Administration and Control (NAFDAC) has given
approval for the use of Pfizer COVID-19 vaccine in Nigeria.
Mojisola
Adeyeye, director-general of NAFDAC, made the announcement during a media
briefing on Friday in Abuja.
The NAFDAC
DG noted that the vaccine is for emergency use.
The
approval is coming over two months after the agency greenlit the use of the
Oxford/AstraZeneca vaccine in the country.
Nigeria
received close to 4.5 million doses of the Oxford/AstraZeneca vaccine — 3.94
million delivered via the United Nations-led COVAX facility, while others are
donations from India and private organisations.
The
rollout began on March 5, and according to the National Primary Health Care
Development Agency (NPHCDA), more than one million Nigerians have received the
first dose of the vaccine.
Faisal
Shuaib, executive director of NPHCDA, had said 8,439 Nigerians reported mild
side effects after receiving the AstraZeneca vaccine.
On April
26, the federal government announced that it was expecting to receive 29.8
million doses of the Johnson & Johnson vaccine through the African Union
(AU).
The
government also said it will take delivery of more vaccines through the UN-led
COVAX facility before the end of June.
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com